• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:王明宇,杨丽娜,仝雅琪,丁彦春.养心氏片治疗不稳定型心绞痛典型病例分析[J].药学研究,2019,38(7):427-430[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 3190次   下载 2831次 本文二维码信息
码上扫一扫!
养心氏片治疗不稳定型心绞痛典型病例分析
王明宇1,2,杨丽娜1,3,仝雅琪1,2,丁彦春1
字体:加大+|默认|缩小-
(1.大连医科大学附属第二医院心内科,辽宁 大连 116027;2.大连医科大学研究生院,辽宁 大连 116044;3.大连医科大学,辽宁 大连 116044)
摘要:
目的 观察养心氏对冠心病不稳定性心绞痛患者外周血单核细胞表型及功能的影响,探讨养心氏治疗冠心病的可能机制。方法 选择冠心病不稳定性心绞痛典型患者1例,分别记录入选者的基本信息及血脂、肝功、肾功、血清胱抑素C等指标。检测单核细胞CD163、CD206、IL-10、IL-12的表达,ELISA法检测血清中IL-10、IL-12及TNF-α浓度,并对患者进行综合生活质量评分:西雅图心绞痛调查量表(SAQ)、广泛性焦虑自评量表(GAD-7)、9条目病人健康问卷(PHQ-9)评估。结果 经过养心氏联合常规药物治疗后,患者单核细胞CD14+CD163+CD206+表达上调,而CD14+CD163-CD206-表达下调;促炎症因子IL-12、TNF-α表达下降,而抗炎因子IL-10较治疗前表达升高,改善西雅图量表评分,降低GAD-7广泛性焦虑量表、抑郁量表评分。结论 养心氏片可以促进巨噬细胞表型转变,改变冠心病患者的炎症状态,延缓动脉粥样硬化的发展,治疗冠心病不稳定型心绞痛。同时能够达到双心治疗的目的。
关键词:  养心氏片  单核细胞表型  冠心病  炎症因子
DOI:10.13506/j.cnki.jpr.2019.07.013
基金项目:
Analysis of typical cases of unstable angina in the treatment of Yangxinshi Tablets
WANG Mingyu1,2,YANG Lina1,3,TONG Yaqi1,2,DING Yanchun1
(1.Department of Cardiology,The Second Affiliated Hospital of Dalian Medical University,Dalian 116027,China;2.Graduate School,Dalian Medical University,Dalian 116044,China;3.Dalian Medical University,Dalian 116044,China)
Abstract:
Objective This article explored the possible mechanism of Yangxinshi Tablet (YXST) 's treatment of coronary heart disease by observing the effect of YXST's on the phenotype and function of peripheral blood mononuclear cells in patients with unstable angina pectoris of coronary heart disease.Methods One typical patient with unstable angina pectoris of coronary heart disease was selected. The basic information, blood lipid, liver function, kidney function and serum cystatin C were recorded. Monocytes were extracted from peripheral venous blood, and the expression of CD163, CD206, IL-10 and IL-12 in monocytes was detected by flow cytometry. The levels of IL-10, IL-12 and TNF-alpha in serum were measured by ELISA. The patients were assessed by comprehensive quality of life scale: Seattle Angina Questionnaire (SAQ), General Anxiety Self-Rating Scale (GAD-7), and 9-item Patient Health Questionnaire (PHQ-9).Results After YXST combination of conventional drugs treatment, the expression of CD14+CD163+CD206+ in monocytes was up-regulated, while the expression of CD14+CD163-CD206-was down-regulated.The expression of pro-inflammatory factors IL-12 and TNF-alpha decreased, while the expression of anti-inflammatory factor IL-10 increased compared with before treatment.The Seattle Scale score was improved,and the scores of GAD-7 General Anxiety Scale and Depression Scale were decreased.Conclusion YXST play an anti-atherosclerosis role by may promoting the phenotype transformation of macrophages, changing the inflammatory state of patients with coronary heart disease.YXST have the effect of double heart treatment.
Key words:  Yangxinshi Tablet  Monocyte phenotype  Coronary heart disease  Inflammatory factors
今日访问量:2337    总访问量:55338708
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司